PAVmed Inc. (PAVM) Financial Statements (2024 and earlier)

Company Profile

Business Address 360 MADISON AVENUE
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments39,74477,25817,2566,2198,2221,535
Cash and cash equivalents39,74477,25817,2566,2198,2221,535
Receivables17200    
Prepaid expense3001,856   74
Other undisclosed current assets3,8653,3231,68532823814
Total current assets:43,92682,63718,9416,5488,4601,623
Noncurrent Assets
Operating lease, right-of-use asset3,037   
Property, plant and equipment2,4511,585  3616
Intangible assets, net (including goodwill)3,4452,029    
Intangible assets, net (excluding goodwill)3,4452,029    
Other noncurrent assets1,121725837   
Other undisclosed noncurrent assets    693  
Total noncurrent assets:10,0544,3398376933616
TOTAL ASSETS:53,98086,97619,7787,2408,4961,640
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,7054,2592,3253,7403,0701,570
Employee-related liabilities3,1511,777   
Accounts payable2,704  2,3531,739864
Accrued liabilities3,705  1,3871,331706
Other undisclosed accounts payable and accrued liabilities (2,704)1,108548   
Debt33,650 14,960 7,903 
Derivative instruments and hedges, liabilities      
Other undisclosed current liabilities3,845  8,139 973
Total current liabilities:41,2004,25917,28511,87910,9732,544
Noncurrent Liabilities
Long-term debt and lease obligation      1,944
Long-term debt, excluding current maturities      1,944
Liabilities, other than long-term debt1,846     
Operating lease, liability1,846   
Total noncurrent liabilities:1,846    1,944
Other undisclosed liabilities  3,2992,966   
Total liabilities:43,0467,55820,25111,87910,9734,488
Equity
Equity, attributable to parent, including:(9,681)61,6661,896(3,824)(2,315)(2,848)
Preferred stock2,6952,419    
Common stock958664402715
Treasury stock, value (408)     
Additional paid in capital216,106198,07187,57047,55432,61914,012
Accumulated deficit(228,169)(138,910)(88,275)(53,715)(36,993)(17,908)
Other undisclosed equity, attributable to parent   2,5372,2962,0321,033
Equity, attributable to noncontrolling interest20,61517,752(2,369)(814)(162) 
Total equity:10,93479,418(473)(4,638)(2,476)(2,848)
TOTAL LIABILITIES AND EQUITY:53,98086,97619,7787,2408,4961,640

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues377500    
Net investment income      
Cost of revenue(3,614)(585)    
Gross profit:(3,237)(85)    
Operating expenses(87,690)(54,308)(23,351)(14,295)(10,563)(8,034)
Other undisclosed operating loss      
Operating loss:(90,927)(54,393)(23,351)(14,295)(10,563)(8,034)
Nonoperating expense
(Other Nonoperating expense)
(12,311)(1,733)(12,537)(2,973)(7,610)(1,485)
Interest and debt expense(5,434)(3,715)(6,497)1,831(615)(725)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   6,497(1,831)615725
Loss from continuing operations before equity method investments, income taxes:(108,672)(59,841)(35,888)(17,268)(18,173)(9,519)
Other undisclosed income from continuing operations before income taxes5,4343,715    
Loss from continuing operations before income taxes:(103,238)(56,126)(35,888)(17,268)(18,173)(9,519)
Income tax benefit  18,9378,7188,150 577
Loss from continuing operations:(103,238)(37,189)(27,170)(9,118)(18,173)(8,943)
Loss before gain (loss) on sale of properties:(37,189)(27,170)(9,118)(18,173)(8,943)
Other undisclosed net income (loss)  (18,937)(8,718)(8,150)18,377 
Net income (loss):(103,238)(56,126)(35,888)(17,268)204(8,943)
Net income attributable to noncontrolling interest14,2555,7791,612811204 
Other undisclosed net loss attributable to parent     (18,377)(577)
Net loss attributable to parent:(88,983)(50,347)(34,276)(16,457)(17,969)(9,519)
Preferred stock dividends and other adjustments    (26)(113)
Other undisclosed net loss available to common stockholders, basic(281)(283)(287)(270)(756)(766)
Net loss available to common stockholders, diluted:(89,264)(50,630)(34,563)(16,727)(18,751)(10,398)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(103,238)(56,126)(35,888)(17,268)204(8,943)
Comprehensive income (loss):(103,238)(56,126)(35,888)(17,268)204(8,943)
Comprehensive income, net of tax, attributable to noncontrolling interest14,2555,7791,612811204 
Comprehensive income (loss), net of tax, attributable to parent:(88,983)(50,347)(34,276)(16,457)408(8,943)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: